Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases
about
Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System InfectionsEvolving Identification of Blood Cells Associated with Clinically Isolated Syndrome: Importance of Time since Clinical Presentation and Diagnostic MRI.A complex role of herpes viruses in the disease process of multiple sclerosis.Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosisParadoxical Immune Responses in Non-HIV Cryptococcal MeningitisImmune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis.Pioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes.Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccinationInsufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosisThe best basic science paper in multiple sclerosis in 2014: important role for the choroid plexus in the central nervous system entry of leukocytes.Human CD56bright NK Cells: An Update.Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.Regulatory Functions of Natural Killer Cells in Multiple Sclerosis.Spinal Arachnoiditis as a Complication of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Adults.Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation.Flow cytometric analysis of T cell/monocyte ratio in clinically isolated syndrome identifies patients at risk of rapid disease progression.Intrathecal CD4(+) and CD8(+) T-cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients.Pharmacodynamic effects of daclizumab in the intrathecal compartment.Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis.New Multiple Sclerosis Disease Severity Scale Predicts Future Accumulation of Disability.The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.Promise, Progress, and Pitfalls in the Search for Central Nervous System Biomarkers in Neuroimmunological Diseases: A Role for Cerebrospinal Fluid Immunophenotyping.CNS: Not an immunoprivilaged site anymore but a virtual secondary lymphoid organ.Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System.Cerebrospinal fluid γδ T cell frequency is age-related: a case control study of 435 children with inflammatory and non-inflammatory neurologic disorders.Effect of ceralifimod (ONO-4641) on lymphocytes and cardiac function: Randomized, double-blind, placebo-controlled trial with an open-label fingolimod arm.Cerebrospinal Fluid Cytokines Correlate With Aseptic Meningitis and Blood-Brain Barrier Function in Neonatal-Onset Multisystem Inflammatory Disease: Central Nervous System Biomarkers in Neonatal-Onset Multisystem Inflammatory Disease Correlate With C
P2860
Q26774211-9FE3741C-05A1-4FC4-9EF0-F4BDF1BB6947Q33838991-5F9AF536-888E-47E7-8392-C0A1D1F529E6Q34078589-A91931D1-5836-4AA3-9893-6A0FB90F6272Q35619174-F8E21812-6B15-49EB-8D48-E5BD0E537432Q35645083-25B484AA-6072-4A63-B547-76E379021D0DQ35848490-1B92A6B9-C9BE-4087-B256-606D61C6EEECQ36410286-25DE82FB-3932-4D8E-89B0-FF2818144DF4Q36521247-3CA941B3-3361-4B91-86F2-5D97D2008150Q36639659-BD15032B-5520-44DB-9847-34A09D0A3225Q38365346-5CA76B5A-1A6D-40EC-9F67-9AE25405C075Q38781384-AE1BDA49-1E30-4300-8547-DEB268881AABQ39025444-76FA2AF6-D4A9-4E87-B9FD-9588A7E19081Q39032832-9808A3DF-8016-40A2-93D8-536098DBD5E2Q39067727-E955FA09-F875-4D59-ACA4-3A0A36EA276BQ39302587-7F1B8D52-4987-4462-97DB-2184227990E6Q40749805-23AA0B25-6936-493A-822F-7C105192B596Q40934895-BB569DB5-8D90-4393-A820-310E6B3E383FQ40962441-C1DBF4E4-C457-4786-AE69-AD412B8F3313Q41615056-49F217B1-8169-472B-80FA-687FE249B05BQ45974017-1A5BE0F4-103E-45AA-8C60-6329315EA0F5Q47109739-A07624DD-5F94-4224-93E4-9526F35EFB6BQ47657261-14E9400C-6275-48F4-ADBC-A0E161A8B5A1Q48091718-349F0A27-CC62-43F3-BB6C-9E77C319B1E5Q48266534-DE64AF12-3C85-43B0-B993-9140EA8D4B8CQ50868161-7125C567-D670-4FD6-B9BA-E2C8ACDE1454Q52952840-788BBAED-5115-4708-9EE6-1ACA6F0D0D02Q59151402-E4D03432-AD66-4C9A-AA39-5BB969E8DCC6
P2860
Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Comprehensive immunophenotypin ...... th neuroimmunological diseases
@ast
Comprehensive immunophenotypin ...... th neuroimmunological diseases
@en
Comprehensive immunophenotypin ...... th neuroimmunological diseases
@en-gb
Comprehensive immunophenotypin ...... th neuroimmunological diseases
@nl
type
label
Comprehensive immunophenotypin ...... th neuroimmunological diseases
@ast
Comprehensive immunophenotypin ...... th neuroimmunological diseases
@en
Comprehensive immunophenotypin ...... th neuroimmunological diseases
@en-gb
Comprehensive immunophenotypin ...... th neuroimmunological diseases
@nl
prefLabel
Comprehensive immunophenotypin ...... th neuroimmunological diseases
@ast
Comprehensive immunophenotypin ...... th neuroimmunological diseases
@en
Comprehensive immunophenotypin ...... th neuroimmunological diseases
@en-gb
Comprehensive immunophenotypin ...... th neuroimmunological diseases
@nl
P2093
P2860
P50
P356
P1476
Comprehensive immunophenotypin ...... th neuroimmunological diseases
@en
P2093
Alan D Salgado
Bibiana Bielekova
Camilo Toro
Elena Romm
Ina Mexhitaj
Irene Cortese
Joan Ohayon
Peter Williamson
Raphaela Goldbach-Mansky
Simone C Wuest
P2860
P304
P356
10.4049/JIMMUNOL.1302884
P407
P577
2014-03-15T00:00:00Z